| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nurix Therapeutics, Inc. (NRIX) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. NRIX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 50.0K | $932.5K | - | |
| CFO | 47.4K | $884.5K | - | |
| Dir | 22.6K | $421.2K | - | |
| Other | 15.0K | $279.8K | - | |
| Other | 13.6K | $253.2K | -8,148 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 | Hansen Gwenn73 | Chief Scientific Officer | Sale+OE | 400 | $29.13 | $11,652.00 | -2.7% | -45.3% | -57.1% | |
| Nov 10, 2021 | Ring Christine77 | General Counsel | Sale+OE | 1,200 | $32.38 | $38,856.00 | -48.3% | -42.7% | -59.0% | |
| Nov 1, 2021 | Hansen Gwenn73 | Chief Scientific Officer | Sale+OE | 400 | $33.24 | $13,296.00 | -2.7% | -46.0% | -61.8% | |
| Oct 27, 2021 | Ring Christine77 | General Counsel | Sale+OE | 800 | $35.25 | $28,200.00 | -38.4% | -42.6% | -64.0% | |
| Oct 27, 2021 | Hansen Gwenn73 | Chief Scientific Officer | Sale+OE | 400 | $35.00 | $14,000.00 | -2.7% | -42.6% | -64.0% | |
| Oct 11, 2021 | Ring Christine77 | General Counsel | Sale+OE | 1,200 | $27.36 | $32,832.00 | -48.3% | -17.0% | -60.6% | |
| Oct 1, 2021 | Hansen Gwenn73 | Chief Scientific Officer | Sale+OE | 400 | $29.92 | $11,968.00 | -2.7% | -4.0% | -58.3% | |
| Sep 10, 2021 | Ring Christine77 | General Counsel | Sale+OE | 2,000 | $35.93 | $71,860.17 | -25.1% | -19.2% | -55.7% | |
| Sep 7, 2021 | Ring Christine77 | General Counsel | Sale+OE | 3,200 | $35.25 | $112,800.00 | -71.3% | -21.2% | -54.2% | |
| Sep 7, 2021 | Hansen Gwenn73 | Chief Scientific Officer | Sale+OE | 1,600 | $35.00 | $56,000.00 | -10.1% | -21.2% | -54.2% |